Gregory Oakes

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Brooklyn, NY
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Eric W. Blanchard, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Gregory Oakes

Form 4 holding Chief Executive Officer, Director

Landos Biopharma, Inc.

Security class
Restricted Stock Unit
Shares / value
0
Estimated value
$0
Report date
23 May 2024
Price
$0.6900
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

First Wave BioPharma, Inc.

Security class
Stock option (right to buy)
Shares / value
34,482
Estimated value
Report date
03 Jan 2022
Price
Ownership
Direct
Underlying class
Common stock, par value $0.0001 per share
Underlying amount
Form 4 holding Chief Executive Officer, Director

Landos Biopharma, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
23 May 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Gregory Oakes

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .